WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Reducing Readmissions in High-Risk Ostomates

Not Applicable

Terminated

Conditions: Ileostomy

Interventions: Other: Pre-operative education (standard of care)
Other: Home health care visits (standard of care)
Other: Follow-up post-operative visits
Other: Patient Data Collection Form
Other: Healthcare Utilization Form
Other: The City of Hope QOL Survey for Ostomy Patients
Other: Phone call with CWOCN or PA

First Posted Date: 2016-01-18

Last Posted Date: 2018-10-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 94

Registration Number: NCT02658123

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Ibrutinib
Procedure: Radical prostatectomy

First Posted Date: 2015-12-31

Last Posted Date: 2025-01-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 27

Registration Number: NCT02643667

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers

Phase 1

Completed

Conditions: Cancer of the Esophagus
Esophageal Cancer
Esophageal Neoplasms

Interventions: Drug: Pembrolizumab
Radiation: Brachytherapy
Procedure: Endoscopic biopsy
Procedure: Computed tomography-guided biopsy
Procedure: Peripheral blood collection

First Posted Date: 2015-12-30

Last Posted Date: 2021-11-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 16

Registration Number: NCT02642809

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum

Phase 2

Completed

Conditions: Cancer of Rectum
Rectum Neoplasms
Rectal Cancer
Adenocarcinoma of the Rectum
Cancer of the Rectum
Neoplasm, Rectum
Rectum Cancer

Interventions: Radiation: Radiation
Drug: Oxaliplatin
Drug: Leucovorin
Drug: Fluorouracil

First Posted Date: 2015-12-29

Last Posted Date: 2021-02-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT02641691

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

Phase 2

Completed

Conditions: Hodgkin Disease
Chronic Myelogenous Leukemia
Non-Hodgkin's Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma
Acute Myelogenous Leukemia
Hodgkin's Disease
Myeloproliferative Neoplasm
Acute Lymphoblastic Leukemia
Hodgkins Disease

Interventions: Drug: BL-8040
Procedure: Hematopoietic cell transplant
Procedure: Leukapheresis

First Posted Date: 2015-12-24

Last Posted Date: 2023-11-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 50

Registration Number: NCT02639559

Locations: 🇺🇸
Northside Hospital Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Contraceptive Choice Center

Completed

Conditions: Contraception
Unintended Pregnancy
Family Planning

First Posted Date: 2015-12-17

Last Posted Date: 2021-06-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2664

Registration Number: NCT02633631

Locations: 🇺🇸
Division of Clinical Research at Washington University, Saint Louis, Missouri, United States

MK-3475 Immunotherapy in Endometrial Carcinoma

Phase 1

Completed

Conditions: Endometrial Cancer
Endometrial Carcinoma
Neoplasms, Endometrial

Interventions: Drug: MK-3475
Procedure: Surgical resection (standard of care)
Drug: Paclitaxel (standard of care)
Drug: Carboplatin (standard of care)
Radiation: Radiation (standard of care)
Procedure: Endometrial biopsy
Procedure: Peripheral blood draw

First Posted Date: 2015-12-15

Last Posted Date: 2025-01-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 10

Registration Number: NCT02630823

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Confocal Laser Microlaryngoscopy (CLMx)

Not Applicable

Withdrawn

Conditions: Laryngeal Neoplasm
Laryngeal Dysplasia

Interventions: Drug: Fluorescein injection, USP 10%
Device: Confocal laser microlaryngoscopy
Procedure: Biopsy (standard of care)
Procedure: KTP laser photoablation (standard of care)

First Posted Date: 2015-12-11

Last Posted Date: 2016-09-09

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02628496

Communicating Multiple Disease Risks

Phase 1

Completed

Conditions: Healthy

Interventions: Behavioral: Cognitive interview
Other: Survey

First Posted Date: 2015-12-03

Last Posted Date: 2017-11-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1191

Registration Number: NCT02621671

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Physical Activity Intervention in African American Men After Radical Prostatectomy

Not Applicable

Withdrawn

Conditions: Prostate Cancer
Prostatectomy

Interventions: Other: Community Health Activities Model Program for Seniors (CHAMPS)
Other: Lifetime Total Physical Activity Questionnaire
Other: Expanded Prostate Cancer Index Composite (EPIC)
Other: International Physical Activity Prevalence Study Environmental Module
Other: Godin Leisure-Time Exercise Questionnaire (GLTEQ)
Other: Questionnaire regarding behavior/lifestyle changes since diagnosis
Other: 12 week Walking Program
Other: 12 week Resistance Training Program

First Posted Date: 2015-12-03

Last Posted Date: 2016-01-29

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02621684

Home Terms & Conditions Privacy Policy